Issue Date: July 18, 2016 | Web Date: July 13, 2016
Money flows for drug service firms
Three events converged in the pharmaceutical services sector last week to serve as a reminder that Western drug manufacturing and research service firms are on a roll.
Patheon’s launch of an initial public offering (IPO) of stock; Cambrex’s completion of an expansion at its Charles City, Iowa, site; and Albany Molecular Research Inc.’s acquisition of Euticals all indicate that the sector is strong and growing in the U.S. and Europe.
. . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society